KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Change in Cash (2017 - 2025)

Historic Change in Cash for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $328762.0.

  • Co-Diagnostics' Change in Cash rose 11073.95% to $328762.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $646313.0, marking a year-over-year increase of 1588.24%. This contributed to the annual value of -$12.0 million for FY2024, which is 4869.61% down from last year.
  • According to the latest figures from Q3 2025, Co-Diagnostics' Change in Cash is $328762.0, which was up 11073.95% from $9.2 million recorded in Q2 2025.
  • Over the past 5 years, Co-Diagnostics' Change in Cash peaked at $14.8 million during Q1 2021, and registered a low of -$58.5 million during Q4 2022.
  • Over the past 5 years, Co-Diagnostics' median Change in Cash value was $328762.0 (recorded in 2025), while the average stood at -$1.7 million.
  • Per our database at Business Quant, Co-Diagnostics' Change in Cash soared by 95706.86% in 2021 and then tumbled by 108393.54% in 2022.
  • Over the past 5 years, Co-Diagnostics' Change in Cash (Quarter) stood at $5.9 million in 2021, then crashed by 1083.94% to -$58.5 million in 2022, then surged by 107.99% to $4.7 million in 2023, then plummeted by 268.08% to -$7.9 million in 2024, then surged by 104.18% to $328762.0 in 2025.
  • Its Change in Cash stands at $328762.0 for Q3 2025, versus $9.2 million for Q2 2025 and -$1.0 million for Q1 2025.